Related Experiment Video
Updated: Sep 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis
Clara Vigneron1, Frédéric Pène2, Julien Charpentier3
1Service de médecine intensive-réanimation, Hôpital Cochin, AP-HP. Centre. 27 rue du Faubourg Saint Jacques, 75014 Paris, France; AP-HP. Centre - Université de Paris, 27 rue du Faubourg Saint Jacques, Paris 75014, France.
Insights
Systemic sclerosis (SSc) patients admitted to the ICU can experience severe, life-threatening cardiac dysfunction. While this cardiac dysfunction may be reversible, it is linked to a poor long-term prognosis for SSc patients.
Area of Science:
- Cardiology
- Rheumatology
- Intensive Care Medicine
Background:
- Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by fibrosis, vascular dysfunction, and immune dysregulation.
- Cardiac involvement is a significant cause of morbidity and mortality in SSc patients.
- Acute cardiac dysfunction in SSc patients admitted to the ICU is not well-characterized.
Purpose of the Study:
- To describe the clinical presentation, management, and outcomes of SSc patients with acute cardiac dysfunction in the ICU.
- To highlight the specific cardiac manifestations and their reversibility in this patient population.
Main Methods:
- Retrospective study of SSc patients admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021.
- Analysis of clinical data, cardiac biomarkers, electrocardiogram (ECG) findings, echocardiographic parameters, and treatment strategies.
- Evaluation of patient survival during ICU stay and at 6 months post-discharge.
Main Results:
- Nine female SSc patients were included, predominantly with diffuse SSc and digital ulcers.
- Most patients presented with cardiac symptoms and ECG modifications, along with elevated troponin and Nt-pro-BNP levels.
- Severe left ventricular ejection fraction (LVEF) impairment was observed, requiring intensive cardiovascular support; however, LVEF showed spontaneous improvement during ICU stay and returned to baseline within 6 months.
- Seven patients (78%) survived the ICU stay, but only 4 (44%) were alive at 6 months.
Conclusions:
- SSc patients can experience uncommon, severe, and life-threatening acute cardiac dysfunction in the ICU.
- This cardiac dysfunction, though potentially reversible, is associated with a poor long-term prognosis.
- Early recognition and management of cardiac dysfunction are crucial in SSc patients admitted to the ICU.
Objective:
To describe systemic sclerosis (SSc) heart involvement in the ICU.
Methods:
We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021.
Results:
9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocardiogram modifications. Biological exams revealed elevated troponin (705 μg/l [421-1582]) and Nt-pro-BNP (16,062 ng/l [10419-40,738]). Patients exhibited severe left ventricular ejection fraction (LVEF) impairment (20% [10-20] vs 58% [53-60] before ICU admission (p = 0.0002)) requiring vasopressors and/or inotropes for 7 patients (78%) and mechanical ventilation or renal replacement therapy for 4 patients (44%). LVEF spontaneously improved during ICU stay (LVEF 40% [30-40] vs 20% [10-20], p = 0.0007) and returned to baseline within 6 months following ICU discharge (LVEF 53% [31-61] vs 58% [53-60]). Seven (78%) patients survived the ICU-stay and 4 (44%) were alive at 6 months.
Conclusion:
We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be reversible but remains associated with a poor long-term prognosis.
More Related Videos
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Introduction Cardiac Emergencies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations